dabigatran has been researched along with Hematochezia in 154 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 115 (74.68) | 24.3611 |
| 2020's | 39 (25.32) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, TF; Chen, MC; Chen, SW; Chu, PH; Chung, CM; Kuan, FC; Lin, YS; Lip, GYH; Wu, M; Wu, VC | 1 |
| An, J; Duan, L; Huang, CW; Lee, MS; Sim, JJ | 1 |
| Ágústsson, AS; Björnsson, ES; Guðmundsdóttir, BR; Hreinsson, JP; Ingason, AB; Lund, SH; Önundarson, PT; Pálsson, DA; Reynisson, IE; Rumba, E | 1 |
| Fu, G; Liu, Z; Wang, Y; Yin, L; Zhang, K | 1 |
| Bitton, E; Clark, NP; Coates, J; Delate, T; Fink, KM; Hendje, A; Knowles, C; Ly, S; Olson, KL | 1 |
| Abe, K; Amano, H; Asaoka, Y; Honda, T; Kodashima, S; Komatsuda, S; Kozuma, K; Manabe, D; Tanaka, A; Yamamoto, H; Yamamoto, T; Yanagisawa, D | 1 |
| Aigner, E; Balcar, L; Bartl, S; Datz, C; Gensluckner, S; Hametner-Schreil, S; Hofer, H; Lampichler, K; Lindorfer, A; Mandorfer, M; Pomej, K; Reiberger, T; Schäfer, B; Scheiner, B; Schöfl, R; Semmler, G; Trauner, M; Zoller, H | 1 |
| Al Kasasbeh, M; Al-Abdouh, A; Barbarawi, M; Barbarawi, O; Corcoran, J; Mhanna, M; Obeidat, K; Pickett, CC | 1 |
| Chen, C; Chen, X; Huang, N; Jiang, S; Lv, M; Wu, T; Zhang, J | 1 |
| Agustsson, AS; Bjornsson, ES; Gudmundsdottir, BR; Hreinsson, JP; Ingason, AB; Lund, SH; Onundarson, PT; Palsson, DA; Reynisson, IE; Rumba, E | 1 |
| Burgos-Gonzalez, A; Huerta, C; Peñalver, MJ; Pulido, J; Sordo, L; Soriano, LC | 1 |
| Björnsson, ES; Hreinsson, JP; Ingason, AB | 1 |
| Arioli, D; Athanasiou, A; Ballestri, S; Capitelli, M; Cappi, C; Coluccio, V; Di Girolamo, M; Marietta, M; Marrazzo, A; Romagnoli, E | 1 |
| Kalka, I; Kornowski, R; Rossman, H; Segal, E; Talmor-Barkan, Y; Witberg, G; Yacovzada, NS | 1 |
| Brigida, M; Candelli, M; Gabrielli, M; Ojetti, V; Petruzziello, C; Saviano, A | 1 |
| Abraham, NS; Barkun, AN; Douketis, J; Hansen-Barkun, C; Kaplovitch, E; Liederman, Z; Majid, A; Martel, M; Schulman, S; Spyropoulos, AC | 1 |
| Björck, F; Jansson, M; Norrving, B; Renlund, H; Själander, A; Själander, S; Sjögren, V | 1 |
| Malý, J; Moudallel, S; Rydant, S; Steurbaut, S; van den Eynde, C | 1 |
| Apolinario, M; Firth, C; Keddis, MT; Lim, ES; Shamoun, F; Zhang, N | 1 |
| Al-Hussainy, N; Kragholm, KH; Lip, GYH; Lundbye-Christensen, S; Pareek, M; Riahi, S; Therkelsen, SK; Torp-Pedersen, C | 1 |
| Butt, JH; Fosbøl, EL; Garcia, D; Køber, L; Li, A; Peterson, ED; Torp-Pedersen, C; Xian, Y | 1 |
| Huggan, P; Humphries, K; Martynoga, R; Stiles, M | 1 |
| Bolek, T; Galajda, P; Kubisz, P; Mokáň, M; Samoš, M; Škorňová, I; Staško, J | 1 |
| Almenar-Bonet, L; Barge-Caballero, E; Blasco-Peiró, T; Carrasco Ávalos, F; Crespo-Leiro, MG; de la Fuente-Galán, L; Díaz-Molina, B; Díez-López, C; González-Vilchez, F; López Granados, A; López-Vilella, R; Mirabet-Pérez, S; Rangel-Sousa, D; Segovia-Cubero, J; Zatarain-Nicolás, E | 1 |
| Młodawska, E; Sobkowicz, B; Tomaszuk-Kazberuk, A; van Ryn, J; Łopatowska, P | 1 |
| Bernstein, RA; Clark, CL; Douketis, J; Fanikos, J; Fermann, GJ; Fiore, GJ; Frost, A; Jahromi, B; Johnson, C; Merli, G; Peacock, WF; Pollack, CV; Silber, S; Villines, TC | 1 |
| Albrecht, H; Hagel, AF; Konturek, PC; Maass, LS; Neurath, MF; Raithel, M | 1 |
| Edwards, JK; Lund, JL; Poole, C; Simpson, RJ; Stürmer, T; Webster-Clark, M | 2 |
| Ham, SA; Micic, D; Sengupta, N; Tapaskar, N | 1 |
| Brahmbhatt, B; Devani, K; Radadiya, D; Reddy, C | 1 |
| Chan, FK; Guo, CL; Lam, KL; Lau, LH; Mak, JW; Ng, SC; Wong, GL; Wong, SH; Yip, TC | 1 |
| Côté, R; Dorais, M; Martel, MJ; Perreault, S; Qazi, JZ; Schnitzer, ME | 1 |
| Oh, HJ; Park, BJ; Ryu, KH; Yoon, BH | 1 |
| Choi, EK; Han, KD; Jung, JH; Kwon, S; Lee, SR; Lip, GYH; Oh, S | 1 |
| Barnes, GD; Cuker, A; Dawwas, GK; Dietrich, E; Leonard, CE; Lewis, JD | 1 |
| Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L | 1 |
| Han, KD; Kim, BS; Kim, HK; Kim, YJ; Lee, H; Lee, HJ; Lee, SP; Park, JB | 1 |
| Benamouzig, R; Deutsch, D; Fauchier, L; Guenoun, M | 1 |
| Jiang, H; Jiang, Y; Lv, J; Ma, H; Zeng, H | 1 |
| Deitelzweig, S; Dhamane, AD; Ferri, M; Jiang, J; Kang, A; Keshishian, AV; Klem, C; Lip, GYH; Luo, X; Yuce, H; Zhang, Y | 1 |
| Chen, J; Chen, M; Fang, Z; Jiang, S; Lv, M; Qian, J; Wu, S; Xu, W; Zeng, Z; Zhang, J | 1 |
| Burr, N; Corp, A; Kane, JS; Lummis, K; Sood, R; Subramanian, V | 1 |
| Ay, C; Domanovits, H; Levy, JH; Sengoelge, G; Simon, A; Spiel, AO | 1 |
| Chan, KA; Chen, HM; Lai, CL; Liao, MT; Lin, TT | 1 |
| Barkun, AN; Dorreen, A; Huynh, T; Martel, M; Miller, CS | 1 |
| Flint, R; Hamer, P; Trip, J | 1 |
| Kido, K; Scalese, MJ | 1 |
| Hu, SJ; Wu, T; Xu, WW | 1 |
| Jolobe, OM | 1 |
| Lip, GYH; Makaritsis, K; Michel, P; Ntaios, G; Papavasileiou, V; Vemmos, K | 1 |
| Bézie, Y; Bourguignon, S; Chevalier, D; Jamet, N; Paubel, P; Thivilliers, AP | 1 |
| Brodie, MM; Newman, JC; Rockey, DC; Smith, T | 1 |
| Akitsu, K; Fujino, T; Ikeda, T; Koike, H; Koike, M; Shinohara, M; Suzuki, T; Yao, S; Yuzawa, H | 1 |
| Doctor, N; Leung, S; Mourafetis, J | 1 |
| Martínez González, J; Rodríguez de Santiago, E; Sierra Morales, M | 1 |
| Aisenberg, J; Brueckmann, M; Chatterjee-Murphy, P; Connolly, S; Desai, J; Ezekowitz, M; Flack, KF; Ilgenfritz, J; Kolb, JM; Reilly, P; Wallentin, LC | 1 |
| Abe, K; Aoyagi, H; Isono, A; Kita, H; Kodashima, S; Kozuma, K; Maruyama, K; Watari, Y; Yamamoto, T | 1 |
| Becker, M; Ganter, C; Hegemann, I; Müller, D; Spahn, DR; Widmer, CC | 1 |
| Arena, G; Baratta, A; Bianchi, S; Catarzi, S; Conti, A; Covelli, A; Dell'Amico, I; Mazzucchelli, M; Molesti, D; Orlandi, G; Pampana, A; Perrotta, ME; Tognarelli, A; Torri, T | 1 |
| Bai, Y; Carmo, J; Esteve-Pastor, MA; Lip, GYH; Marín, F; Orenes-Piñero, E; Proietti, M; Rivera-Caravaca, JM; Roldán, V; Romanazzi, I; Romiti, GF | 1 |
| Chang, SH; Chu, PH; Kuo, CF; Tseng, HJ; Wang, CL; Wen, MS; Wu, VC | 1 |
| Alvarez-Madrazo, S; Bennie, M; Mueller, T; Robertson, C; Wu, O | 1 |
| Chung, CP; Daugherty, JR; Dupont, WD; Murray, KT; Ray, WA; Smalley, WE; Stein, CM | 1 |
| Aisenberg, J; Elsaesser, A; Glund, S; Huisman, MV; Klok, FA; Lopes, RD; Pollack, CV; Reilly, P; Van der Wall, SJ; van Ryn, J | 1 |
| Guo, X; Liu, Y; Sun, Z; Xu, Y; Zhang, Y | 1 |
| Connolly, SJ; Siegal, DM | 1 |
| Ahn, JY; Bang, CS; Cho, YK; Joo, MK; Jung, HK; Kim, BJ; Kim, BW; Kim, JS; Lee, BE; Lee, JH; Park, CH; Park, JM; Yang, HJ | 1 |
| Fleddermann, AM; Hayes, CH; Magalski, A; Main, ML | 1 |
| Abouelfath, A; Bénichou, J; Blin, P; Cottin, Y; Droz, C; Dureau-Pournin, C; Lassalle, R; Mismetti, P; Moore, N | 1 |
| Chen, H; Deng, Y; Li, S; Tong, Y; Zou, L | 1 |
| Belk, KW; Nautiyal, A; Singh, S | 1 |
| Holm, J; Taskiran, M | 1 |
| Reichman, ME; Southworth, MR; Unger, EF | 1 |
| Callréus, T; Due, KM; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F | 1 |
| Aisenberg, J; Desai, J; Kolb, JM; Weitz, JI | 1 |
| Hallows, KR; Henry, BL; Maw, TT; Nolin, TD; Pastor-Soler, NM; Singh, T; Unruh, ML | 1 |
| Brardjanian, S; Coton, T; Diallo, I; Guisset, M; Jourdan, S; Mallaret, C | 1 |
| Aisenberg, J; Desai, J; Granger, CB; Weitz, JI | 1 |
| Baron, TH; Kamath, PS; McBane, RD | 1 |
| Keighley-Jones, L; Nash, MJ; Pike, G; Thachil, J | 1 |
| Bell, S; Dawes, M; Nand, J | 1 |
| Braun, G; Messmann, H | 1 |
| Adam, G; Akbal, E; Asik, M; Bilen, Oİ; Binnetoglu, E; Gunes, F; Sen, H; Temiz, A; Ukinc, K | 1 |
| González-Rico, MA; Juan-García, I; Miguel-Carrasco, A; Puchades-Montesa, MJ; Ramos-Tomás, C; Ribés-Cruz, JJ; Solís-Salguero, MA; Tejedor-Alonso, S; Tomás-Simó, P; Torregrosa-Maicas, I; Zambrano-Esteves, P | 1 |
| Celik, S; Sipahi, I; Tozun, N | 1 |
| Katz, MH | 1 |
| Bastovansky, A; Finsterer, J; Paul, G; Stöllberger, C | 1 |
| Davis, M; Kabra, R; Kimmons, LA; Oliphant, CS; Segars, BV | 1 |
| Ditch, K; Miller, MA; Ross, B; Tran, M | 1 |
| Carter, A; Corbett, S; George, M; Sarda, P | 1 |
| Chintala, M; Keohane, C; Li, Q; Ni, W; O'Neill, K; Shang, J; Wang, M; Wei, H | 1 |
| Henry, BL; Kumar, R; Smith, RE | 1 |
| Hess, T; Konturek, P | 1 |
| Ellis, MH | 1 |
| Berla, M; Feinberg, J; Grabowitz, L; Levy, Y; Rotman-Pikielny, P | 1 |
| Chrischilles, E; Cram, P; Jones, M; Mazur, A; Vaughan Sarrazin, MS | 1 |
| Brueckmann, M; Clemens, A; Konstantinides, S; Lip, GY; Noack, H; Strack, A | 1 |
| Husein, H; Samo, S; Sherid, M; Sifuentes, H; Spurr, C; Sridhar, S; Sulaiman, S; Thiruvaiyaru, D; Tupper, R | 1 |
| Goulding, MR; Graham, DJ; Houstoun, M; Kelman, JA; Levenson, M; MaCurdy, TE; Mott, K; Reichman, ME; Sheu, TC; Southworth, MR; Wernecke, M; Worrall, C; Zhang, R | 1 |
| Campbell, P; Lam, T; Nguyen, C; Tran, TH | 1 |
| Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM | 1 |
| Hennes, O; Nyby, S | 1 |
| Ali, A; Assaly, R; Hamouda, D; Khan, A; Mbaso, C; Paul, S; Prashar, R; Shah, S | 1 |
| Loffredo, L; Perri, L; Violi, F | 1 |
| Husein, H; Samo, S; Sherid, M; Sifuentes, H; Spurr, C; Sridhar, S; Sulaiman, S; Tupper, R | 1 |
| Abe, J; Kato, Y; Kinosada, Y; Nagasawa, H; Nakamura, M; Nakayama, Y; Suzuki, T; Suzuki, Y; Ueda, N; Umetsu, R | 1 |
| Abraham, NS; Alexander, GC; Crown, W; Haas, LR; Heien, H; Shah, ND; Singh, S | 1 |
| Alexander, GC; Chang, HY; Singh, S; Tang, W; Zhou, M | 1 |
| Amato, A; Dentali, F; Dumonceau, JM; Paggi, S; Radaelli, F; Repici, A; Rondonotti, E | 1 |
| Chan, EW; He, Y; Lau, WC; Leung, WK; Mok, MT; Tong, TS; Wong, IC | 1 |
| Fang, G; Farley, JF; Gehi, AK; Lauffenburger, JC; Rhoney, DH | 1 |
| Beavers, C; Pahs, L; Schuler, P | 1 |
| Berry, A; Ehrlich, C; Tsu, LV; Wald, E | 1 |
| Jones, JM; Leedahl, DD; Ryan, HM; Tieszen, M | 1 |
| Avgil-Tsadok, M; Behlouli, H; Eisenberg, MJ; Essebag, V; Jackevicius, CA; Pilote, L; Rahme, E | 1 |
| Srivali, N; Thongprayoon, C; Ungprasert, P | 1 |
| Azimi, N; Forest, CP; Holden, A | 1 |
| Di Minno, A; Di Minno, G; Spadarella, E; Spadarella, G; Tremoli, E | 1 |
| Bouget, J; Oger, E | 1 |
| Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC | 1 |
| Al-Khalili, F; Benson, L; Lindström, C | 1 |
| Dolginsky, M; Kym, E; Nolting, L; Orrico, KB; Romanelli, RJ | 1 |
| Anand, S; Chan, EW; He, Y; Leung, WK; Li, X; Siu, CW; Wong, IC | 1 |
| Gauthier-Lewis, ML; Riley, TR; Riley, TT; Sanchez, CK | 1 |
| Aksoy, H; Ata, N; Ayturk, M; Dal, K; Ozkan, S; Ozturk, M; Şabanoglu, C; Tanalp, AC; Topaloglu, C; Yavuz, B; Yavuz, BB | 1 |
| Battat, E; Bitterman, H; Dotan, SG; Eikelboom, JW; Ellis, MH; Ginsberg, JS; Hammerman, A; Hirsh, J; Neuman, T | 1 |
| Alhashem, HM; Avendano, C; Hayes, BD; Winters, ME | 1 |
| Berger, K; Lesch, CA; Sin, JH | 1 |
| Milling, TJ; Spyropoulos, AC | 2 |
| Kawasugi, K; Kita, H; Kuyama, Y; Shirai, T; Yamamoto, T | 1 |
| Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH | 1 |
| Pan, H; Wang, L; Xie, Y | 1 |
| Chillarige, Y; Goulding, MR; Graham, DJ; Hsueh, YH; Izem, R; Kelman, JA; Liao, J; MaCurdy, TE; Mott, K; Reichman, ME; Southworth, MR; Wei, Y; Wernecke, M; Worrall, C | 1 |
| Aisenberg, J; Brueckmann, M; Chatterjee, P; Connolly, S; Desai, J; Ezekowitz, M; Flack, KF; Ilgenfritz, J; Kolb, JM; Reilly, P; Wallentin, LC; Yusuf, S | 1 |
| Al-Kahlili, F; Gilstring, Å; Haeggström, A; Risberg, D; Tullberg, U; Wallén, H | 1 |
| Alonso, A; Bengtson, LGS; Chen, LY; Lutsey, PL; MacLehose, RF | 1 |
| Abraham, NS; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yao, X | 1 |
| Biagi, C; Conti, V; Donati, M; Melis, M; Monaco, L; Motola, D; Vaccheri, A; Venegoni, M | 1 |
| Ambrosino, P; Di Minno, A; Di Minno, G; Di Minno, MN; Tremoli, E | 1 |
| Bhatt, DL; Vaduganathan, M | 1 |
| Chang, HY; Singh, S; Tang, W; Zhou, M | 1 |
| Cong, J; Fromm, C; Ganetsky, M; Milling, TJ; Pallin, DJ; Singer, AJ | 1 |
| Lip, GY; Potpara, TS | 1 |
| Cangemi, DJ; Cipher, DJ; Feagins, LA; Krill, T; Spechler, SJ; Weideman, R | 1 |
| Aikens, TH; Chernick, MR; Connolly, SJ; Ezekowitz, MD; Lip, GY; Parekh, A; Pogue, J; Reilly, PA; Wallentin, L; Yang, S; Yusuf, S | 1 |
| Aribaud, A; Drouet, L; Eftekhari, P; Ginisty, S; Huy, PT; Legrand, M; Mateo, J; Payen, D | 1 |
| Kouides, PA; Wychowski, MK | 1 |
| Curtis, JA; Fellows, SE; Rosini, JM; Volz, EG | 1 |
| Boesen, K; Ito, S; Kernan, L; Shirazi, F | 1 |
| Dumkow, LE; Jennings, DL; Peters, M; Voss, JR | 1 |
| Cirra, VR; Kamboj, J; Kamboj, R; Kottalgi, M; Shah, N | 1 |
| Harinstein, LM; Morgan, JW; Russo, N | 1 |
35 review(s) available for dabigatran and Hematochezia
| Article | Year |
|---|---|
Efficacy and Safety of the Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Nonvalvular Atrial Fibrillation and Cancer: A Systematic Review and Network Meta-analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Neoplasms; Network Meta-Analysis; Stroke; Treatment Outcome; Warfarin | 2022 |
Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently Known.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke; Warfarin | 2022 |
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Stroke; Venous Thromboembolism | 2023 |
Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Warfarin | 2022 |
Proton Pump Inhibitors and Dabigatran Therapy: Impact on Gastric Bleeding and Dabigatran Plasma Levels.
Topics: Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Risk Factors | 2019 |
Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? - A systematic review and network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Network Meta-Analysis; Rivaroxaban; Stroke; Warfarin | 2021 |
The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: A network meta-analysis.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Network Meta-Analysis; Observational Studies as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2021 |
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Vitamin K | 2022 |
Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta-analysis.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Rivaroxaban; Stroke; Warfarin | 2021 |
Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Network Meta-Analysis; Rivaroxaban; Stroke; Vitamin K | 2023 |
Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Risk Factors; Warfarin | 2017 |
Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis.
Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism | 2017 |
Management of Oral Anticoagulation Therapy After Gastrointestinal Bleeding: Whether to, When to, and How to Restart an Anticoagulation Therapy.
Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism; Warfarin | 2017 |
Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Clinical Trials as Topic; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Markov Chains; Middle Aged; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Pyridines; Randomized Controlled Trials as Topic; Risk; Thiazoles; Warfarin | 2017 |
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Myocardial Infarction; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin | 2017 |
Differences in safety and efficacy of oral anticoagulants in patients with non-valvular atrial fibrillation: A Bayesian analysis.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Bayes Theorem; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proportional Hazards Models; Pyrazoles; Pyridones; Risk; Rivaroxaban; Stroke; Warfarin | 2019 |
The Role of Acid Suppressants in the Prevention of Anticoagulant-Related Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Antacids; Anticoagulants; Case-Control Studies; Cohort Studies; Coumarins; Dabigatran; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Neoplasms; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thromboembolism; Warfarin | 2019 |
Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Endoscopy; Gastrointestinal Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2013 |
Novel oral anticoagulants in gastroenterology practice.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Gastrointestinal Hemorrhage; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes | 2013 |
New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cholangiopancreatography, Endoscopic Retrograde; Clopidogrel; Dabigatran; Drug Interactions; Fondaparinux; Gastrointestinal Hemorrhage; Humans; Piperazines; Platelet Aggregation Inhibitors; Polysaccharides; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine | 2014 |
[Gastrointestinal bleeding in cardiological patients].
Topics: Algorithms; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Drug Monitoring; Gastrointestinal Hemorrhage; Heart Diseases; Humans; Metabolic Clearance Rate; Morpholines; Phenprocoumon; Platelet Aggregation Inhibitors; Platelet Transfusion; Rivaroxaban; Thiophenes; Vitamin K | 2013 |
A comparison of results of the US food and drug administration's mini-sentinel program with randomized clinical trials: the case of gastrointestinal tract bleeding with dabigatran.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Pharmaceutical; Gastrointestinal Hemorrhage; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin | 2014 |
A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.
Topics: Anticoagulants; Antidotes; Antithrombins; Charcoal; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospitals, University; Humans; Intracranial Hemorrhages; Male; Multiple Organ Failure; Partial Thromboplastin Time; Renal Dialysis; Retrospective Studies; Severity of Illness Index; Stroke; Treatment Outcome | 2015 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Thiazoles; Warfarin | 2015 |
Management of anticoagulation in patients with acute gastrointestinal bleeding.
Topics: Acenocoumarol; Acute Disease; Algorithms; Anticoagulants; Coagulants; Dabigatran; Endoscopy, Gastrointestinal; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Vitamin K; Warfarin | 2015 |
New oral anticoagulants for patients with nonvalvular atrial fibrillation.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles | 2015 |
Gastrointestinal bleeding in patients receiving oral anticoagulation: Current treatment and pharmacological perspectives.
Topics: Anticoagulants; Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Pyrazoles; Pyridones; Warfarin | 2015 |
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
Topics: Age Factors; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2016 |
The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors; Rivaroxaban; Warfarin | 2016 |
Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed.
Topics: Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism | 2016 |
Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed.
Topics: Antithrombins; Clinical Decision-Making; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Practice Guidelines as Topic; Risk Assessment; Thromboembolism | 2016 |
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.
Topics: Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Vitamin K | 2017 |
Treatment of dabigatran-associated bleeding: case report and review of the literature.
Topics: Aged, 80 and over; Algorithms; Antithrombins; Benzimidazoles; Dabigatran; Factor VIIa; Factor VIII; Fibrinogen; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Dialysis; Treatment Outcome | 2013 |
3 trial(s) available for dabigatran and Hematochezia
| Article | Year |
|---|---|
Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrazoles; Pyridones; Rivaroxaban | 2018 |
Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Chemoprevention; Dabigatran; Embolism; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Prevalence; Prospective Studies; Stroke; Warfarin | 2017 |
Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyridines; Risk Factors; Stroke; Treatment Outcome; Vitamin K; Warfarin | 2010 |
116 other study(ies) available for dabigatran and Hematochezia
| Article | Year |
|---|---|
Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Middle Aged; Neoplasms; Rivaroxaban; Taiwan; Venous Thromboembolism | 2021 |
Effectiveness and Safety of Dabigatran in Atrial Fibrillation Patients with Severe Obesity: a Real-World Retrospective Cohort Study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Obesity, Morbid; Retrospective Studies; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2022 |
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants : A Nationwide Propensity Score-Weighted Study.
Topics: Aged; Cohort Studies; Dabigatran; Digestive System Diseases; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Iceland; Male; Propensity Score; Pyrazoles; Pyridones; Rivaroxaban; Ulcer | 2021 |
Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Drug Therapy, Combination; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis | 2022 |
Clinical outcomes of dabigatran use in patients with non-valvular atrial fibrillation and weight >120 kg.
Topics: Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Longitudinal Studies; Retrospective Studies | 2021 |
Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Male; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thrombosis | 2021 |
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Dabigatran; End Stage Liver Disease; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Retrospective Studies; Severity of Illness Index; Vitamin K | 2023 |
A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Rivaroxaban | 2023 |
Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort Study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Stroke; Warfarin | 2023 |
Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Spain; Stroke; Tramadol | 2023 |
Head-to-head efficacy and safety of rivaroxaban, apixaban, and dabigatran in an observational nationwide targeted trial.
Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Rivaroxaban; Stroke | 2022 |
Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy.
Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Child; Cohort Studies; Dabigatran; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Male; Rivaroxaban | 2023 |
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation.
Topics: Administration, Oral; Adolescent; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke; Warfarin | 2023 |
Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Stroke | 2023 |
Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Kidney Transplantation; Retrospective Studies; Rivaroxaban; Stroke; Warfarin | 2023 |
Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia.
Topics: Administration, Oral; Anemia; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Pyridones; Rivaroxaban; Stroke | 2023 |
Direct oral anticoagulant- versus vitamin K antagonist-related gastrointestinal bleeding: Insights from a nationwide cohort.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Cohort Studies; Dabigatran; Denmark; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Logistic Models; Male; Pyrazoles; Pyridones; Rivaroxaban; United States; Vitamin K; Warfarin | 2019 |
Life-threatening bleeding due to persistent dabigatran effect in a patient with sepsis despite idarucizumab therapy and haemodialysis.
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Diagnosis, Differential; Fasciitis, Necrotizing; Gastrointestinal Hemorrhage; Humans; Leg; Male; Middle Aged; Renal Dialysis; Shock, Septic; Streptococcal Infections | 2019 |
Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Cardiac Surgical Procedures; Dabigatran; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors | 2019 |
Redistribution of dabigatran after idarucizumab administration in a 90-year-old woman with renal failure due to persistent large intestinal bleeding.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Renal Insufficiency | 2019 |
The safety of oral anticoagulants registry (SOAR): A national, ED-based study of the evaluation and management of bleeding and bleeding concerns due to the use of oral anticoagulants.
Topics: Aged; Aged, 80 and over; Dabigatran; Emergency Service, Hospital; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Registries; Warfarin | 2020 |
Anticoagulant-related gastrointestinal bleeding: a real-life data analysis on bleeding profiles, frequency and etiology of patients receiving direct oral anticoagulants versus vitamin K antagonists.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Vitamin K; Young Adult | 2019 |
Real-world on-treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults.
Topics: Age Factors; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Female; Gastrointestinal Hemorrhage; Health Services for the Aged; Humans; Male; Medicare; Risk Factors; Stroke; United States; Warfarin | 2020 |
Reweighting Oranges to Apples: Transported RE-LY Trial Versus Nonexperimental Effect Estimates of Anticoagulation in Atrial Fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Medicare; Mortality; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; United States; Warfarin | 2020 |
Restarting Warfarin vs Direct Oral Anticoagulants After Major Gastrointestinal Bleeding and Associated Outcomes in Atrial Fibrillation: A Cohort Study.
Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Humans; Retrospective Studies; Warfarin | 2022 |
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.
Topics: Aged; Anticoagulants; Blood Transfusion; Cohort Studies; Colonic Polyps; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hong Kong; Humans; Male; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban; Thromboembolism; Warfarin | 2022 |
Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Regression Analysis; Rivaroxaban; Warfarin | 2021 |
Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Proton Pump Inhibitors; Rivaroxaban; Stroke; Upper Gastrointestinal Tract; Warfarin | 2022 |
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Comparative Effectiveness Research; Dabigatran; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Male; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; Warfarin | 2021 |
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin | 2021 |
Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Ischemic Stroke; Male; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Risk; Rivaroxaban; Upper Gastrointestinal Tract; Warfarin | 2021 |
Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; United States; Warfarin | 2021 |
The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Drug Administration Schedule; Fatal Outcome; Gastrointestinal Hemorrhage; Hemofiltration; Hemorrhage; Humans; Male; Renal Dialysis; Renal Replacement Therapy; Sepsis | 2017 |
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Transfusion; Cause of Death; Comparative Effectiveness Research; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Logistic Models; Male; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke | 2017 |
Intramural oesophageal haematoma-a rare complication of dabigatran.
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Esophageal Perforation; Female; Gastrointestinal Hemorrhage; Gastroscopy; Hematoma; Hemoptysis; Humans; Mediastinal Diseases; Tomography, X-Ray Computed; Vomiting | 2017 |
Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Craniocerebral Trauma; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Pyrazoles; Pyridines; Pyridones; Stroke; Thiazoles; Warfarin | 2017 |
[Use of a Delphi survey to assess the hospital economic impact of innovative products: The example of idarucizumab a dabigatran-specific reversal agent].
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Dabigatran; Delphi Technique; Drug Costs; Economics, Hospital; France; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Surveys and Questionnaires | 2017 |
Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
Topics: Administration, Oral; Aged; Anticoagulants; Arteriovenous Malformations; Aspirin; Blood Transfusion; Case-Control Studies; Dabigatran; Diverticulum; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Hemorrhoids; Hospitalization; Humans; Male; Middle Aged; Peptic Ulcer; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin | 2018 |
Bleeding with oral anticoagulant dabigatran is highly associated with occult cancers in atrial fibrillation patients.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Japan; Male; Middle Aged; Neoplasms, Unknown Primary; Prevalence; Retrospective Studies; Risk Factors; Stroke; Survival Rate | 2018 |
Treatment of gastrointestinal bleeding with idarucizumab in a patient receiving dabigatran.
Topics: Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Humans; Male; Treatment Outcome | 2018 |
Severe obscure gastrointestinal bleeding successfully treated with idarucizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Male | 2018 |
Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran.
Topics: Administration, Oral; Angiodysplasia; Anticoagulants; Antithrombins; Atrial Fibrillation; Colon; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Odds Ratio; Randomized Controlled Trials as Topic; Rectum; Retrospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2018 |
Ongoing redistribution of dabigatran necessitates repetitive application of idarucizumab.
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Coagulation Tests; Dabigatran; Emergency Medical Services; Female; Gastrointestinal Hemorrhage; Humans; Kidney Diseases | 2018 |
Role of Hypertension and Other Clinical Variables in Prognostication of Patients Presenting to the Emergency Department With Major Bleeding Events.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Blood Glucose; Blood Transfusion; Cardiovascular Diseases; Creatinine; Dabigatran; Emergency Service, Hospital; Epistaxis; Female; Gastrointestinal Hemorrhage; Hematuria; Hemoptysis; Hemorrhage; Humans; Hypertension; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Prognosis; Propensity Score; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Sex Factors; Thiazoles; Warfarin | 2018 |
Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.
Topics: Acenocoumarol; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Pyrazoles; Pyridones; Rivaroxaban; Spain; Stroke | 2018 |
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hepatic Insufficiency; Humans; Male; Proportional Hazards Models; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Warfarin | 2018 |
Comparative safety and effectiveness of direct oral anticoagulants in patients with atrial fibrillation in clinical practice in Scotland.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Scotland; Stroke; Treatment Outcome | 2019 |
Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Male; Middle Aged; Proton Pump Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Upper Gastrointestinal Tract; Warfarin | 2018 |
Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; United States; Venous Thromboembolism; Vitamin K | 2019 |
Idarucizumab for Dabigatran-Related Gastrointestinal Bleeds.
Topics: Antibodies, Monoclonal, Humanized; Dabigatran; Gastrointestinal Hemorrhage; Humans | 2019 |
Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus.
Topics: Adult; Aged; Blood Transfusion; Dabigatran; Echocardiography; Epistaxis; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Ventricles; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left | 2019 |
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS.
Topics: Administration, Oral; Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Data Systems; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Male; Propensity Score; Rivaroxaban; Vitamin K | 2020 |
Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort Study.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Intracranial Hemorrhages; Male; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2020 |
[Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Critical Illness; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Jehovah's Witnesses; Plasma; Treatment Outcome; Treatment Refusal | 2013 |
Dabigatran and postmarketing reports of bleeding.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration; Warfarin | 2013 |
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Denmark; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Intracranial Hemorrhages; Logistic Models; Male; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Pyridines; Registries; Stroke; Warfarin | 2013 |
Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience.
Topics: Accidental Falls; Acute Disease; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Colonic Diseases; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Intestinal Volvulus; Leg Ulcer; Male; Renal Dialysis; Subarachnoid Hemorrhage | 2013 |
[New oral anticoagulants and digestive hemorrhages].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Morpholines; Retrospective Studies; Rivaroxaban; Thiophenes | 2014 |
Plasma dabigatran activity one week after discontinuation despite normal renal function.
Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans | 2013 |
Anticoagulation-associated upper gastrointestinal haemorrhage.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Medical Audit; Upper Gastrointestinal Tract; Warfarin | 2013 |
Gastrointestinal bleeding associated with dabigatran in a patient with panhypopituitarism.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Embolism; Female; Gastrointestinal Hemorrhage; Humans; Hypopituitarism; Treatment Outcome | 2014 |
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, Type 2; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency, Chronic; Thrombophilia; Urinary Tract Infections | 2013 |
Multiple data sources, the best way to gather safety information about medications.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Gastrointestinal Hemorrhage; Humans; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic | 2014 |
Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Stroke | 2013 |
Dabigatran Use in the Real World: A Multihospital System Experience.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Inappropriate Prescribing; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies | 2014 |
Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Massachusetts; Middle Aged; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome | 2014 |
Hip arthroplasty fatality related to dabigatran induced gastrointestinal haemorrhage.
Topics: Aged; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Pyridines; Venous Thromboembolism | 2014 |
A novel approach to assess the spontaneous gastrointestinal bleeding risk of antithrombotic agents using Apc(min/+) mice.
Topics: Age Factors; Animals; Benzimidazoles; Clopidogrel; Dabigatran; Disease Models, Animal; Drug Evaluation, Preclinical; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Genes, APC; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Pyrazoles; Pyridines; Pyridones; Risk Factors; Ticlopidine; Warfarin | 2014 |
No(AC) free lunches: promises and pitfalls of novel oral anticoagulants.
Topics: Antithrombins; Benzimidazoles; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Pyridines | 2014 |
Dabigatran etexilate linked to fatal gastrointestinal hemorrhage.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; Dabigatran; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Prothrombin Time; Pyridines | 2014 |
Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Drug Substitution; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; International Normalized Ratio; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Stroke; United States; United States Department of Veterans Affairs; Warfarin | 2014 |
Anticoagulant-related gastrointestinal bleeding--could this facilitate early detection of benign or malignant gastrointestinal lesions?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Early Detection of Cancer; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Incidence; Morpholines; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Thiophenes; Warfarin | 2014 |
Risk of gastrointestinal bleeding with dabigatran: a head-to-head comparative study with rivaroxaban.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Morpholines; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes | 2014 |
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Dose-Response Relationship, Drug; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Kidney Diseases; Medicare; Proportional Hazards Models; Retrospective Studies; Risk; Socioeconomic Factors; Stroke; Treatment Outcome; United States; Warfarin | 2015 |
Bleeding incidence and real-life prescribing practices with dabigatran use in an acute care setting.
Topics: Adult; Antithrombins; Atrial Fibrillation; Dabigatran; Gastrointestinal Hemorrhage; Humans; Incidence; Retrospective Studies | 2014 |
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment | 2015 |
[Fatal bleeding diarrhoea during dabigatran etexilate therapy].
Topics: Acute Kidney Injury; Aged; Antithrombins; Dabigatran; Diarrhea; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male | 2014 |
Management of dabigatran-induced bleeding with continuous venovenous hemodialysis.
Topics: Aged; Antithrombins; Blood Coagulation Tests; Blood Transfusion; Dabigatran; Drug Overdose; Female; Gastrointestinal Hemorrhage; Humans; Renal Dialysis | 2015 |
Gastrointestinal bleeding with dabigatran, a comparative study with warfarin: a multicenter experience.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Warfarin | 2015 |
Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Aging; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Kidney; Male; Middle Aged; Odds Ratio; United States; United States Food and Drug Administration; Warfarin | 2015 |
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Medicaid; Middle Aged; Morpholines; Patient Selection; Practice Patterns, Physicians'; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin | 2015 |
Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study.
Topics: Administration, Oral; Adult; Age Factors; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Morpholines; Observational Studies as Topic; Retrospective Studies; Risk Factors; Rivaroxaban; Thiophenes; United States; Warfarin | 2015 |
Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Hong Kong; Humans; Incidence; Male; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors | 2015 |
The Real-World Treatment of Hemorrhages Associated With Dabigatran and Rivaroxaban: A Multicenter Evaluation.
Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Factors; Coagulants; Cohort Studies; Dabigatran; Epistaxis; Erythrocyte Transfusion; Factor VIIa; Factor VIII; Female; Fibrinogen; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Plasma; Platelet Transfusion; Recombinant Proteins; Retrospective Studies; Rivaroxaban | 2015 |
Modified HAS-BLED Score and Risk of Major Bleeding in Patients Receiving Dabigatran and Rivaroxaban: A Retrospective, Case-Control Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Case-Control Studies; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Logistic Models; Male; Retrospective Studies; Risk Assessment; Risk Factors; Rivaroxaban | 2015 |
Successful hemostasis and reversal of highly elevated PT/INR after dabigatran etexilate use in a patient with acute kidney injury.
Topics: Acute Kidney Injury; Aged; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; International Normalized Ratio; Male; Shock | 2016 |
Dabigatran use in elderly patients with atrial fibrillation.
Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Databases, Factual; Drug Utilization Review; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Kaplan-Meier Estimate; Male; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Quebec; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Warfarin | 2016 |
The options of reversal of a dabigatran effect.
Topics: Acute Kidney Injury; Antithrombins; Dabigatran; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; International Normalized Ratio; Male | 2015 |
Emergency admissions for major haemorrhage associated with direct oral anticoagulants.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Patient Admission; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Venous Thrombosis | 2015 |
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin | 2016 |
The safety and persistence of non-vitamin-K-antagonist oral anticoagulants in atrial fibrillation patients treated in a well structured atrial fibrillation clinic.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiovascular Diseases; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Patient Safety; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Vitamin K | 2016 |
Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Cohort Studies; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Platelet Aggregation Inhibitors; Retrospective Studies; Warfarin | 2017 |
A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Registries; Stroke; Warfarin | 2016 |
Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intracranial Hemorrhages; Israel; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke; Warfarin | 2016 |
Persistent life-threatening hemorrhage after administration of idarucizumab.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Dabigatran; Duodenal Diseases; Embolization, Therapeutic; Gastrointestinal Hemorrhage; Humans; Male; Treatment Failure | 2017 |
Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cardiac Surgical Procedures; Dabigatran; Emergencies; Female; Gastrointestinal Hemorrhage; Heart Transplantation; Hemorrhage; Hemostatics; Heparin; Humans; Incidence; International Normalized Ratio; Intracranial Hemorrhages; Laparotomy; Male; Middle Aged; Preoperative Care; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Surgical Procedures, Operative; Thrombocytopenia; Thromboembolism; Vitamin K; Warfarin | 2016 |
Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
Topics: Aged; Aged, 80 and over; Anticoagulants; Cohort Studies; Dabigatran; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Japan; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Vitamin K; Warfarin | 2016 |
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Thromboembolism; Warfarin | 2016 |
Management of Major Bleeding Related to Novel Oral Anticoagulant Agents Use in Frail Elderly Adults.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidotes; Antithrombins; Dabigatran; Female; Frail Elderly; Gastrointestinal Hemorrhage; Hemostatic Techniques; Humans; Male; Renal Dialysis | 2016 |
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Valve Diseases; Humans; Kaplan-Meier Estimate; Male; Medicare; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Treatment Outcome; United States | 2016 |
[Gastrointestinal bleeding during treatment with nonvitamin K antagonist oral anticoagulants (NOACs) may be caused by malignant lesions].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Gastrointestinal Neoplasms; Humans; Male; Pilot Projects; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Vitamin K | 2016 |
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Rivaroxaban; Warfarin | 2017 |
Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Young Adult | 2017 |
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
Topics: Administration, Oral; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Child; Child, Preschool; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Warfarin; World Health Organization; Young Adult | 2017 |
Gastrointestinal Bleeding With Oral Anticoagulation: Understanding the Scope of the Problem.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Embolism; Gastrointestinal Hemorrhage; Humans; Neoplasms; Stroke; Warfarin | 2017 |
Risk of Gastrointestinal Bleeding Among Dabigatran Users - A Self Controlled Case Series Analysis.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Male; Middle Aged; Risk Assessment; Young Adult | 2017 |
Management of Major Bleeding Events in Patients Treated With Dabigatran for Nonvalvular Atrial Fibrillation: A Retrospective, Multicenter Review.
Topics: Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Erythrocyte Transfusion; Female; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies | 2017 |
Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Data Collection; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Observational Studies as Topic; Patient Selection; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Registries; Rivaroxaban; Stroke; Warfarin | 2017 |
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Incidence; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin | 2017 |
The use of dabigatran in elderly patients.
Topics: Administration, Oral; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Device Removal; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Humans; Pyridines; Shock, Hemorrhagic; Stroke | 2011 |
Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Creatinine; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; International Normalized Ratio; Patient Selection; Renal Dialysis | 2012 |
Hemorrhagic gastritis with dabigatran in a patient with renal insufficiency.
Topics: Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; Blood Component Transfusion; Dabigatran; Emergency Service, Hospital; Endoscopy, Gastrointestinal; Gastritis; Gastrointestinal Hemorrhage; Humans; Male; Plasma; Pyridines; Renal Insufficiency, Chronic | 2013 |
Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male | 2012 |
Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Fatal Outcome; Gastrointestinal Hemorrhage; Humans; Male; Multiple Organ Failure; Partial Thromboplastin Time; Plasma; Shock, Hemorrhagic | 2012 |
Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidotes; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Half-Life; Hematocrit; Hemoglobins; Humans; Ibuprofen; Middle Aged; Plasmapheresis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Respiration, Artificial | 2012 |